Atherectomy Devices Market

The global Atherectomy Devices Market is valued at USD 1.04 Billion in 2024 and is projected to reach a value of USD 2.485 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.25% between 2025 and 2035.

Premium Insights

The Atherectomy Devices market is poised for robust growth in the coming years, driven by a confluence of factors. The impact of the COVID-19 pandemic, marked by a significant reduction in cardiac surgery volumes and elective cases, is gradually subsiding with the easing of restrictions worldwide. The global market is witnessing a resurgence as healthcare systems recover and patients increasingly opt for minimally invasive surgeries. The adoption of such procedures is bolstered by continuous advancements in percutaneous coronary intervention (PCI) and the development of minimally invasive cardiac surgery (MICS) techniques. Moreover, the market is witnessing a product development and commercialization surge, exemplified by recent launches such as Philips' Nexcimer laser system. Reimbursement reforms illustrated by the Centers for Medicare and Medicaid Services (CMS) increasing reimbursement for peripheral intravascular lithotripsy procedures in 2022 further enhance the markets growth prospects. However, stringent regulatory scenarios remain a potential constraint.

• Based on the Product, the Directional Atherectomy Devices segment is expected to sustain its dominance in the market owing to its ability to remove plaque and restore the blood flow in a more controlled and precise manner.
• By End User, the Hospitals & Surgical Centers segment is expected to witness maximum market growth over the projected period.
• By Application, the Cardiovascular segment dominated the largest market share globally from 2023 to 2030 owing to the rising prevalence of cardiovascular diseases and the increasing adoption of Atherectomy Devices for their treatment.
• In 2022, North America led the market with the highest revenue share of 41.30%.
• The Asia Pacific region is expected to witness maximum market growth during the forecast period.

Top Market Trends

1. Minimally Invasive Procedures Surge: The demand for

   minimally invasive

   surgeries is escalating, boasting a success rate of around 90%. Atherectomy procedures align with this trend, offering reduced trauma and faster patient recovery, contributing to the markets growth.
2. Technological Advancements Driving Adoption: Technological innovations, including laser Atherectomy Devices, are amplifying market development. Advancements such as novel image-guided atherectomy systems are enhancing treatment effectiveness, fostering demand.
3. Reimbursement Reforms Impacting Growth: Increasing reimbursement policies for atherectomy procedures, exemplified by CMSs elevated reimbursements, are positively influencing market expansion, and incentivizing treatment adoption.
4. Global Health Trends & Disease Prevalence: Poor eating habits, sedentary lifestyles, and escalating cardiovascular diseases worldwide are fueling the demand for Atherectomy Devices, pushing market growth.

Economic Insights

The market has witnessed a volatile trajectory, initially disrupted by the COVID-19 pandemics impact on elective surgeries. The subsequent recovery post-easing of restrictions and increasing healthcare investments, especially in North America, have led to a resurgence in demand for Atherectomy Devices. Favorable reimbursement policies, technological advancements, and strategic industry moves are contributing to steady market growth. Europes market, although mature, is experiencing price depreciation in most segments, yet new investments in innovative premium products are offsetting declines.

Market Segmentation

The Global Atherectomy Devices Market is categorized into the segments as mentioned below:

{{Segmentation_Ext}}

Based on Product

Directional Atherectomy Devices will account for the Largest Market Share in the Projected Period

In 2022, Directional Atherectomy Devices dominated the market. Directional Atherectomy Devices offer several advantages over other techniques, such as their ability to remove all types of plaque and their high success rates in restoring blood flow. Additionally, these devices have shown promising results in reducing the risk of restenosis and the need for additional interventions. As a result, the directional Atherectomy Devices segment is expected to experience significant growth and remain the preferred choice for physicians and patients alike.

Based on Application

The Cardiovascular segment will Dominate the Market during the Forecast Period

The cardiovascular segment is expected to experience the greatest market growth during the forecast period. Atherectomy Devices are primarily used in the treatment of cardiovascular diseases, particularly in the removal of plaque buildup in the arteries. The high prevalence of cardiovascular diseases, along with the increasing demand for minimally invasive procedures, is driving the growth of this segment. Additionally, advancements in technology and the introduction of innovative devices with enhanced capabilities are further propelling market growth. The cardiovascular segment is anticipated to witness significant growth during the forecast period, owing to the rising prevalence of cardiovascular diseases and the increasing adoption of Atherectomy Devices for their treatment.

Based on End User

Hospitals & Surgical Centers segment Expected to Dominate the Market during Forecast Period

The cardiovascular segment is expected to experience the greatest market growth during the forecast period. This can be attributed to the increasing number of patients opting for atherectomy procedures in hospitals and surgical centers. Hospitals and surgical centers generally have advanced infrastructure and skilled healthcare professionals, making them the preferred choice for performing atherectomy procedures. Additionally, hospitals and surgical centers generally have a wide range of specialized equipment, including Atherectomy Devices, which further contributes to their dominance in the market. Moreover, these facilities have better accessibility to patients, higher patient footfall, and effective reimbursement policies, which further enhance their market share in the Atherectomy Devices market.

Based on Region

North America will Lead the Market in the Forecast Period

North America asserted its dominance in the Atherectomy Devices market, capturing the largest revenue share of 41.30% in 2022. With advanced healthcare infrastructure, high FDA-approved device availability, and favorable reimbursement policies, the region continues to drive market growth through continuous R&D investments and a rising preference for minimally invasive surgeries.

The Asia Pacific regions precious metal market is anticipated to grow at a noteworthy CAGR over the forecast period. The regions increasing prevalence of cardiovascular diseases, coupled with rising product approvals and advancements, signifies substantial opportunities for market expansion, as witnessed by recent approvals like Lepu Medical Technology Co. Ltd.s peripheral cutting balloon in China.

Competitive Landscape

The competitive landscape in the Atherectomy Devices market is vibrant, characterized by key players focusing on R&D, product innovations, and strategic collaborations to enhance their market presence. Notable recent developments include significant acquisitions and partnerships, such as Abbotts acquisition of Cardiovascular Systems Inc., aimed at expanding product portfolios and strengthening footholds in the competitive arena. Key players like Boston Scientific Corporation, Medtronic, and Koninklijke Philips N.V. are investing heavily in obtaining regulatory approvals and advancing their atherectomy systems' commercialization.

The key players in the global Atherectomy Devices market include - Boston Scientific Corporation (U.S.) among others.

Recent Market Developments

• In October 2023, Cardio Flow secured a 510(k) clearance for its orbital atherectomy peripheral platform, leveraging modern mechanisms to address plaque blockages, further enriching the competitive landscape.
• February 2023, witnessed Abbotts strategic move to acquire Cardiovascular Systems Inc., augmenting its portfolio and market position significantly, emphasizing the growing consolidation trend in the sector.

Segmentation of the Global Atherectomy Devices Market